Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penglai Jinchuang Group is a large-scale Chinese conglomerate headquartered in Penglai, Shandong Province. While primarily recognized for its extensive gold mining and processing operations, the group has established a significant presence in the life sciences and healthcare sectors through its subsidiaries, including Penglai Jinchuang Pharmaceutical and Jinchuang Biological Project. The company's pharmaceutical division specializes in the development and manufacture of traditional Chinese medicines (TCM) and chemical drugs, with a focus on respiratory health products such as cough syrups and loquat-based remedies. Additionally, the group produces a wide range of dietary supplements, biological calcium products, and plant extracts, serving both domestic and international markets. Through its biological engineering arm, the group also engages in the production of pharmaceutical raw materials and health foods. As a diversified state-owned enterprise, Penglai Jinchuang Group integrates research, production, and trade across multiple industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peng Lai Jin Chuang Group.